14. Chronic inflammatory demyelinating polyneuropathy Clinical trials / Disease details

Clinical trials : 175 / Drugs : 161 - (DrugBank : 41) / Drug target genes : 13 - Drug target pathways : 24

23 trials found

diseases per page:

Showing 1 to 10 of 23 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-003107-35-CZ (EUCTR)	18/10/2021	05/03/2020	A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in ...	Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, a ...	Chronic Inflammatory Demyelinating Polyneuropathy;Therapeutic area: Diseases [C] - Nervous System Di ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: EFGARTIGIMOD ALFA Product Name: Efgartigimod P ...	argenx BVBA	NULL	Not Recruiting			Female: yes Male: yes	360	Phase 2	Serbia;United States;Czechia;Spain;Ukraine;Israel;Russian Federation;United Kingdom;Italy;France;Hun ...
2	EUCTR2019-003107-35-AT (EUCTR)	27/07/2021	21/08/2020	A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in ...	Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, a ...	Chronic Inflammatory Demyelinating Polyneuropathy MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: EFGARTIGIMOD ALFA Product Name: Efgartigimod P ...	argenx BVBA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	360	Phase 2	Serbia;United States;Czechia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;Fr ...
3	EUCTR2019-003076-39-AT (EUCTR)	21/04/2021	01/10/2020	A study to assess the safety and efficacy of a subcutaneous formulation of efgartigimod in adults wi ...	A Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adu ...	Chronic Inflammatory Demyelinating Polyneuropathy MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: EFGARTIGIMOD ALFA Product Name: Efgartigimod P ...	argenx BVBA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	400	Phase 2	Serbia;United States;Taiwan;Spain;Ukraine;Israel;Russian Federation;Italy;France;Denmark;Netherlands ...
4	EUCTR2019-003107-35-NL (EUCTR)	25/09/2020	01/05/2020	A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in ...	Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, a ...	Chronic Inflammatory Demyelinating Polyneuropathy MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: Efgartigimod alfa Other descriptive name: ARGX ...	argenx BVBA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	360	Phase 2	Serbia;United States;Czechia;Spain;Ukraine;Israel;Russian Federation;United Kingdom;Italy;France;Cze ...
5	EUCTR2019-003107-35-DK (EUCTR)	22/09/2020	12/08/2020	A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in ...	Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, a ...	Chronic Inflammatory Demyelinating Polyneuropathy MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: EFGARTIGIMOD ALFA Product Name: Efgartigimod P ...	argenx BVBA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	360	Phase 2	Serbia;United States;Czechia;Spain;Ukraine;Israel;Russian Federation;United Kingdom;Italy;France;Hun ...
6	EUCTR2019-003107-35-BG (EUCTR)	04/09/2020	11/06/2020	A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in ...	Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, a ...	Chronic Inflammatory Demyelinating Polyneuropathy MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: EFGARTIGIMOD ALFA Product Name: Efgartigimod P ...	argenx BVBA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	360	Phase 2	Serbia;United States;Czechia;Spain;Ukraine;Israel;Russian Federation;United Kingdom;Italy;France;Hun ...
7	EUCTR2019-003076-39-DK (EUCTR)	19/08/2020	23/06/2020	A study to assess the safety and efficacy of a subcutaneous formulation of efgartigimod in adults wi ...	A Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adu ...	Chronic Inflammatory Demyelinating Polyneuropathy MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: EFGARTIGIMOD ALFA Other descriptive name: ARGX ...	argenx BVBA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	400	Phase 2	Serbia;United States;Czechia;Spain;Ukraine;Austria;Russian Federation;Israel;United Kingdom;Italy;Fr ...
8	EUCTR2019-003076-39-CZ (EUCTR)	12/08/2020	05/03/2020	A study to assess the safety and efficacy of a subcutaneous formulation of efgartigimod in adults wi ...	A Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adu ...	Chronic Inflammatory Demyelinating Polyneuropathy MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: Efgartigimod alfa Other descriptive name: ARGX ...	argenx BVBA	NULL	Not Recruiting			Female: yes Male: yes	400	Phase 2	United States;Serbia;Czechia;Spain;Ukraine;Austria;Russian Federation;Israel;United Kingdom;Italy;Fr ...
9	EUCTR2019-003107-35-BE (EUCTR)	04/08/2020	20/03/2020	A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in ...	Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, a ...	Chronic Inflammatory Demyelinating Polyneuropathy MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: EFGARTIGIMOD ALFA Product Name: Efgartigimod P ...	argenx BVBA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	360	Phase 2	United States;Serbia;Taiwan;Spain;Ukraine;Russian Federation;Israel;Italy;France;Denmark;Latvia;Neth ...
10	EUCTR2019-003107-35-DE (EUCTR)	15/07/2020	24/02/2020	A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in ...	Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, a ...	Chronic Inflammatory Demyelinating Polyneuropathy MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: EFGARTIGIMOD ALFA Product Name: Efgartigimod P ...	argenx BVBA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	360	Phase 2	United States;Serbia;Taiwan;Spain;Ukraine;Russian Federation;Israel;Italy;France;Denmark;Latvia;Neth ...

First Previous1 2 3Next Last